BlackRock’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$186M Sell
8,842,635
-313,882
-3% -$6.6M ﹤0.01% 1648
2025
Q1
$150M Buy
9,156,517
+779,461
+9% +$12.8M ﹤0.01% 1744
2024
Q4
$215M Buy
8,377,056
+696,115
+9% +$17.9M ﹤0.01% 1625
2024
Q3
$243M Buy
7,680,941
+873,151
+13% +$27.7M 0.01% 1529
2024
Q2
$239M Buy
6,807,790
+842,377
+14% +$29.6M 0.01% 1499
2024
Q1
$262M Buy
5,965,413
+528,745
+10% +$23.2M 0.01% 1458
2023
Q4
$193M Buy
5,436,668
+843,095
+18% +$30M ﹤0.01% 1654
2023
Q3
$124M Buy
4,593,573
+237,877
+5% +$6.42M ﹤0.01% 1849
2023
Q2
$102M Buy
4,355,696
+806,603
+23% +$19M ﹤0.01% 2013
2023
Q1
$48.7M Buy
3,549,093
+12,363
+0.3% +$170K ﹤0.01% 2427
2022
Q4
$64.3M Buy
3,536,730
+861,174
+32% +$15.6M ﹤0.01% 2273
2022
Q3
$39.9M Buy
2,675,556
+53,268
+2% +$795K ﹤0.01% 2592
2022
Q2
$36.2M Buy
2,622,288
+132,011
+5% +$1.82M ﹤0.01% 2673
2022
Q1
$27.9M Sell
2,490,277
-239,442
-9% -$2.68M ﹤0.01% 2901
2021
Q4
$64.5M Sell
2,729,719
-281,947
-9% -$6.67M ﹤0.01% 2459
2021
Q3
$76.8M Buy
3,011,666
+409,243
+16% +$10.4M ﹤0.01% 2352
2021
Q2
$54.6M Buy
2,602,423
+1,195,493
+85% +$25.1M ﹤0.01% 2600
2021
Q1
$33.1M Buy
1,406,930
+192,860
+16% +$4.53M ﹤0.01% 2849
2020
Q4
$17M Buy
1,214,070
+319,057
+36% +$4.47M ﹤0.01% 3027
2020
Q3
$11.2M Buy
895,013
+165,745
+23% +$2.08M ﹤0.01% 3081
2020
Q2
$10.4M Buy
729,268
+691,050
+1,808% +$9.82M ﹤0.01% 3105
2020
Q1
$158K Buy
38,218
+26,774
+234% +$111K ﹤0.01% 4194
2019
Q4
$86K Sell
11,444
-4,173
-27% -$31.4K ﹤0.01% 4403
2019
Q3
$142K Buy
15,617
+7,354
+89% +$66.9K ﹤0.01% 4325
2019
Q2
$82K Buy
+8,263
New +$82K ﹤0.01% 4448